Summary
Tom Brettin is a Senior Scientist and strategic program leader with 12+ years integrating AI, high-performance computing, and genomics to accelerate drug discovery and cancer research. He designs and leads cross-institutional teams and large-funded portfolios, translating deep learning research—ranging from tumor drug-response models to protein-ligand docking and agentic systems—into scalable scientific software and HPC deployments. His career blends hands-on technical work at national labs and research institutions with program-level fiscal stewardship and industry partnerships exploring next-generation accelerators. Tom’s background in biochemistry and plant genetics, paired with continuing education in software architecture and engineering, gives him an uncommon ability to bridge wet-lab biology and production-grade computational systems. He’s known for building distributed bioinformatics infrastructure and for steering collaborative projects that turn complex genomic data into actionable biomedical insight. Based in the Chicago area, he brings a pragmatic, interdisciplinary approach to advancing AI-driven biomedical discovery.
12 years of coding experience
Continuing Education, Software Engineering Practices, Software Engineering, Continuing Education, Software Engineering Practices, Software Engineering at Texas A&M University
Continuing Education, Compter Science, Continuing Education, Compter Science at Boston University
Continuing Education, Computer Science, Continuing Education, Computer Science at Framingham State University
Bachelor of Science (B.S.), Biochemistry, Bachelor of Science (B.S.), Biochemistry at Michigan State University
Continuing Education, Computer Science, Continuing Education, Computer Science at The University of New Mexico
Continuing Education, Software System Architecture, Continuing Education, Software System Architecture at Carnegie Mellon University